No office visit needed
Two receptors, one molecule, one weekly injection.
The only dual-agonist available. Engages both GLP-1 and GIP for stronger appetite control and a broader metabolic effect
2 pathways
GLP-1 + GIP, weekly
GLP-1 / GIP TREATMENTIn stock today
CompoundedTirzepatide(GLP-1 / GIP)
GLP-1/GIP weight care with compounded tirzepatide, reviewed by a licensed provider and fulfilled through a state-licensed compounding pharmacy.
Active Ingredient
Tirzepatide
GLP-1 + GIP dual agonist
Dosage
Once weekly
Provider-guided dosing
Form
Subcutaneous
Multi-dose vial + syringe
Source
503A pharmacy
Compounded per your prescription · U.S. licensed
MONTHLY AND 3 MONTH OPTIONS AVAILABLE
as low as $133/mo
Save $100 today
availableNo office visit neededFSA/HSA eligibleMedication shipped to you
Compounded Tirzepatide is a medication prepared by a state-licensed pharmacy pursuant to a valid prescription from a licensed clinician. Compounded drugs are not FDA-approved as a finished product, though their active ingredients may be FDA-approved. Prescription eligibility is determined by a licensed clinician after intake review.
GLP-1 / GIP TREATMENTIn stock today
Compounded Tirzepatide (GLP-1 / GIP)
GLP-1/GIP weight care with compounded tirzepatide, reviewed by a licensed provider and fulfilled through a state-licensed compounding pharmacy.
Active Ingredient
Tirzepatide
GLP-1 + GIP dual agonist
Dosage
Once weekly
Provider-guided dosing
Form
Subcutaneous
Multi-dose vial + syringe
Source
503A pharmacy
Compounded per your prescription · U.S. licensed
MONTHLY AND 3 MONTH OPTIONS AVAILABLE
as low as $133/mo
Save $100 today
availableNo membership requiredFSA/HSA eligibleFull refund if not eligible
Compounded Tirzepatide is a medication prepared by a state-licensed pharmacy pursuant to a valid prescription from a licensed clinician. Compounded drugs are not FDA-approved as a finished product, though their active ingredients may be FDA-approved. Prescription eligibility is determined by a licensed clinician after intake review.
Benefits of tirzepatide
Sharper fat metabolism
GIP activation supports fat oxidation and insulin sensitivity.
Clinician reviewed
U.S.-licensed clinicians on every prescription, no auto-approvals.
Stronger appetite control
Combined receptor activity quiets hunger more reliably than GLP-1 alone.
Cold-chain shipping
Temperature-controlled delivery, included in your monthly cost.
Two receptors, one molecule, one weekly injection.
The only dual-agonist available. Engages both GLP-1 and GIP for stronger appetite control and a broader metabolic effect
2 pathways
GLP-1 + GIP, weekly
Sharper fat metabolism
GIP activation supports fat oxidation and insulin sensitivity.
Clinician reviewed
U.S.-licensed clinicians on every prescription, no auto-approvals.
Stronger appetite control
Combined receptor activity quiets hunger more reliably than GLP-1 alone.
Cold-chain shipping
Temperature-controlled delivery, included in your monthly cost.
One molecule. Two pathways. Once weekly.
A dual-agonist formulation for weight care, targeting both GLP-1 and GIP receptor pathways as part of a clinically managed program.
2 pathways
GLP-1 + GIP, weekly
A different kind of GLP-1
GIP activation supports fat oxidation and insulin sensitivity.
Clinician reviewed
U.S.-licensed clinicians on every prescription, no auto-approvals.
Less noise
Many patients report a shift in their relationship with food. Talk to your clinician about what to expect.
Cold-chain shipping
Temperature-controlled delivery, included in your monthly cost.
How LumiMeds Works
I'm ready to start
FreePrivateHIPAA
Step 1 • Assessment
Tell us about your health history and goals. Takes about 2 minutes.
ReviewedU.S licensedApproved✓
Step 2 • Provider Review
A licensed provider reviews your intake and determines next steps
Refills
Dr. Walsh
Week 4 check-in, how are you feeling?
Down 6 lbs and energy is up.
24/7
Step 3 • Ongoing Care
Your provider stays one message away for support, questions, and refills.
Quick online assessment • Private
The dual-action science
How Tirzepatide works in the body
Tirzepatide is an active ingredient that interacts with two receptor types — GLP-1 and GIP — that play a role in metabolic regulation.
GLP-1 · appetite & blood sugar
Tirzepatidedual receptor
GIP · fat & metabolic function
GLP-1 receptors
GLP-1 is a naturally occurring hormone involved in appetite and blood sugar regulation. Tirzepatide is designed to interact with these receptors as part of a clinician-managed program.
GIP receptors
GIP is a hormone associated with metabolic function. Tirzepatide is also designed to interact with GIP receptors, which may play a role in how the body processes nutrients.
Dual-receptor interaction
By interacting with both receptor types, tirzepatide engages two pathways involved in metabolic health.
Your dose builds gradually, by design
Starting low and increasing over time helps your body adjust and reduces side effects. Your provider reviews your response at each stage.Starting low and increasing over time gives your body time to adjust. Your provider reviews your response at each stage.
Month 1
2.5mg
The starter dose. A low starting point gives your body time to adapt to the dual-receptor activity with minimal side effects.The starter dose. A low starting point gives your body time to adjust to the dual-receptor activity.
Once weekly · subcutaneous
Month 2
5mg
Dose increases as your body adapts. Many patients notice meaningful appetite changes and reduced cravings at this stage.Many patients notice changes in appetite and energy at this stage.
Once weekly · subcutaneous
Month 3+
10mg
Full therapeutic dose for most patients. Your provider reviews your progress and may continue titrating up to 15mg if appropriate.A higher dose level for patients who have completed the adjustment period. Your provider may continue increasing up to 15mg based on your individual response.
Once weekly · subcutaneous
Doses are prescribed and reviewed by a licensed provider. Your actual titration schedule may vary based on your health history and response to treatment.
Real results from real patients
Real LumiMeds Patient
Before
AfterReal LumiMeds Patient
Before
AfterReal LumiMeds Patient
Before
AfterResults vary. Individual outcomes depend on program adherence, medical history, and other factors. These members were compensated for sharing their experience. Content shared with full consent.
Common questions about Compounded Tirzepatide
Tirzepatide has an established clinical safety record as the active ingredient in FDA-approved Mounjaro and Zepbound. Your compounded medication is prepared at a state-licensed, cGMP-compliant pharmacy. Every prescription is reviewed by a licensed U.S. provider who evaluates your health history before prescribing. As with any medication, side effects are possible — your provider monitors your response throughout treatment.
Still have questions? Contact us
Ready to start?
A short questionnaire.
Your provider handles the rest.
Share your health history online in about 90 seconds. A licensed provider reviews your intake and prescribes if appropriate.
Takes 90 seconds · Private · Always free
No membership requiredFSA/HSA eligibleFull refund if not eligible
Excellent
No membership required
